Immunomodulatory activity of IR700-labelled affibody targeting HER2.
Saved in:
| Title: | Immunomodulatory activity of IR700-labelled affibody targeting HER2. |
|---|---|
| Authors: | Mączyńska J; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland., Da Pieve C; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Burley TA; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Raes F; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Shah A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Saczko J; Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland., Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kramer-Marek G; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. gkramermarek@icr.ac.uk. |
| Source: | Cell death & disease [Cell Death Dis] 2020 Oct 20; Vol. 11 (10), pp. 886. Date of Electronic Publication: 2020 Oct 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
